ALTEOGEN Inc (196170) - Total Liabilities

Latest as of March 2026: ₩216.61 Billion KRW ≈ $146.79 Million USD

Based on the latest financial reports, ALTEOGEN Inc (196170) has total liabilities worth ₩216.61 Billion KRW (≈ $146.79 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

ALTEOGEN Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how ALTEOGEN Inc's total liabilities have evolved over time, based on quarterly financial data. See ALTEOGEN Inc (196170) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

ALTEOGEN Inc Competitors by Total Liabilities

The table below lists competitors of ALTEOGEN Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Lynas Rare EARTHS Ltd AU:LYC	Australia	AU$591.51 Million
Far EasTone Telecommunications Co Ltd TW:4904	Taiwan	NT$85.18 Billion
Meritz Financi KO:138040	Korea	₩132.60 Trillion
Smith & Nephew SNATS Inc NYSE:SNN	USA	$5.17 Billion
Gfl Environmental Holdings Inc TO:GFL	Canada	CA$13.41 Billion
BridgeBio Pharma Inc NASDAQ:BBIO	USA	$2.92 Billion
COLOPLAST SP.ADR 1/10 DK1 F:CBH	Germany	€34.99 Billion
Logitech International S.A. SW:LOGN	Switzerland	CHF1.64 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down ALTEOGEN Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ALTEOGEN Inc (196170) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.41	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.43	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.30	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ALTEOGEN Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ALTEOGEN Inc (2014–2025)

The table below shows the annual total liabilities of ALTEOGEN Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩244.30 Billion ≈ $165.56 Million	+81.07%
2024-12-31	₩134.92 Billion ≈ $91.43 Million	+24.63%
2023-12-31	₩108.26 Billion ≈ $73.37 Million	+11.92%
2022-12-31	₩96.73 Billion ≈ $65.55 Million	-21.74%
2021-12-31	₩123.61 Billion ≈ $83.77 Million	+340.77%
2020-12-31	₩28.04 Billion ≈ $19.00 Million	+75.31%
2019-12-31	₩16.00 Billion ≈ $10.84 Million	+236.41%
2018-12-31	₩4.76 Billion ≈ $3.22 Million	+50.08%
2017-12-31	₩3.17 Billion ≈ $2.15 Million	+16.44%
2016-12-31	₩2.72 Billion ≈ $1.84 Million	+226.01%
2015-12-31	₩834.62 Million ≈ $565.61K	-60.88%
2014-12-31	₩2.13 Billion ≈ $1.45 Million	--

About ALTEOGEN Inc

KQ:196170 Korea Biotechnology

Market Cap

$12.78 Billion

₩18.85 Trillion KRW

Market Cap Rank

#1874 Global

#46 in Korea

Share Price

₩352500.00

Change (1 day)

+1.00%

52-Week Range

₩289500.00 - ₩559000.00

All Time High

₩559000.00